All Q3 FY26 results →
BA

Best Agrolife Ltd

Q3 FY26Fertilizers & Agrochemicals

Best Agrolife Q3 FY26 earnings call: Revenue & Margins

Q3 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹18
Market cap₹743 Cr
P/E25.1
Updated23 Aug 2026
Read4 min read

The short version

Company expects growth to resume from next year after stabilizing inventory and working capital. - Projected revenue for FY 2026 is Rs. Revenue is expected to grow to Rs.

From Best Agrolife Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Company expects growth to resume from next year after stabilizing inventory and working capital.
  • Projected revenue for FY 2026 is Rs. 1,300 to Rs. 1,400 crore, with sales growth anticipated in FY 2027 to Rs. 1,600 - 1,800 crore.
  • Over next two years, revenue expected to exceed past peak levels, driven by patented products.
  • Operating profit margin (OPM) target for FY 2027 is around 16-17%, with a long-term goal up to 20%.
  • Existing production capacity sufficient to support Rs. 2,000+ crore revenue without additional CAPEX.
  • Growth fueled by expanding patented portfolio and new product launches, with improved sales team and policies.

2 more points from Best Agrolife Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Best Agrolife Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Currently, there is no active CAPEX being undertaken ("So, for CAPEX, we are not doing anything as of now" - Vikas Jain, Page 17).
  • The CAPEX plan depends on receiving the balance 75% amount from preferential allotment. Only the initial 25% amount received was used for working capital (Page 17).
  • The company plans to reassess the CAPEX decision "four, five months down the line" and is currently keeping CAPEX on hold (Page 16).
  • Existing capacity is sufficient to achieve revenues beyond Rs. 1,800 crore without adding new capacity (Page 9).

2 more points from Best Agrolife Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Anya Polytech &
Rev 2Mar 1
2Dharmaj Crop
Rev 2Mar 2
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 3Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Best Agrolife Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript does not explicitly mention the current or expected order book or pending orders for Best Agrolife Limited. However, insights related to sales and order environment include: - The company faced lower sales in the current year due to unseasonal rainfall and market conditions but expects recovery starting June next year. - Inventory and sales return issues have been stabilized with stringent policies, aiding better dealer and sales team comfort. - New patented products such as BestMan and Fetagen have shown strong acceptance with over 4 lakh treated acres. - The company expects growth driven by these patented products and improved operational stability. - Export shipments continue on a cash basis with ongoing dossiers in international markets.

2 more points from Best Agrolife Ltd's call on order book

Pro opens every point from 15K+ earnings calls

Best Agrolife Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹156 Cr, net loss ₹37 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Fertilizers & Agrochemicals this season

  • Bhagiradha Chemicals & Industries Ltd (Q3 FY26)

    114.0 crore, up 11% YoY from Rs. Key investor presentation takeaways from Bhagiradha Chemicals & Industries Ltd's Q3 FY26 investor presentation — and how it ran

  • Advance Agrolife Ltd (Q3 FY26)

    Q3 FY26 revenue from operations was ₹1,338 million, up 18% year-on-year (YoY) from ₹1,134 million in Q3 FY25 (Pages 23-24). Key investor presentation takeaways

  • Sumitomo Chemi. (Q3 FY26)

    568.0 crore, down 12% year-on-year from Rs. Key concall takeaways from Sumitomo Chemical India Ltd's Q3 FY26 earnings call — and how it ranks against sector…

  • Dharmaj Crop (Q3 FY26)

    Q3FY26 revenue from operations: ₹1,895 million, a 9% year-on-year (YoY) increase from ₹1,745 million in Q3FY25. Key concall takeaways from Dharmaj Crop Guard…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Best Agrolife Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Best Agrolife Ltd Q3 FY26 results?

Company expects growth to resume from next year after stabilizing inventory and working capital. - Projected revenue for FY 2026 is Rs. Revenue is expected to grow to Rs.

What is Best Agrolife Ltd share price analysis?

Best Agrolife Ltd currently shows a neutral. The stock trades at a P/E of 25.1 with a market cap of ₹743 Cr. Investors should review the full earnings analysis for detailed insights.

Is Best Agrolife Ltd planning capital expenditure?

Currently, there is no active CAPEX being undertaken ("So, for CAPEX, we are not doing anything as of now" - Vikas Jain, Page 17). - The CAPEX plan depends on receiving the balance 75% amount from preferential allotment.

Keep Best Agrolife Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.